Daemen MJ - Search Results

1

Higher levels of advanced glycation endproducts in human carotid atherosclerotic plaques are associated with a rupture-prone phenotype.

Hanssen NM, Wouters K, Huijberts MS, Gijbels MJ, Sluimer JC, Scheijen JL, Heeneman S, Biessen EA, Daemen MJ, Brownlee M, de Kleijn DP, Stehouwer CD, Pasterkamp G, Schalkwijk CG. Hanssen NM, et al. Among authors: daemen mj. Eur Heart J. 2014 May;35(17):1137-46. doi: 10.1093/eurheartj/eht402. Epub 2013 Oct 14. Eur Heart J. 2014. PMID: 24126878

2

Peripheral vascular alterations during experimental heart failure in the rat. Do they exist?

Heeneman S, Leenders PJ, Aarts PJ, Smits JF, Arends JW, Daemen MJ. Heeneman S, et al. Among authors: daemen mj. Arterioscler Thromb Vasc Biol. 1995 Sep;15(9):1503-11. doi: 10.1161/01.atv.15.9.1503. Arterioscler Thromb Vasc Biol. 1995. PMID: 7670966

3

Effects of angiotensin II on cardiac function and peripheral vascular structure during compensated heart failure in the rat.

Heeneman S, Smits JF, Leenders PJ, Schiffers PM, Daemen MJ. Heeneman S, et al. Among authors: daemen mj. Arterioscler Thromb Vasc Biol. 1997 Oct;17(10):1985-94. doi: 10.1161/01.atv.17.10.1985. Arterioscler Thromb Vasc Biol. 1997. PMID: 9351363

4

Both early and delayed anti-CD40L antibody treatment induces a stable plaque phenotype.

Lutgens E, Cleutjens KB, Heeneman S, Koteliansky VE, Burkly LC, Daemen MJ. Lutgens E, et al. Among authors: daemen mj. Proc Natl Acad Sci U S A. 2000 Jun 20;97(13):7464-9. doi: 10.1073/pnas.97.13.7464. Proc Natl Acad Sci U S A. 2000. PMID: 10861013 Free PMC article.

5

Compensatory enlargement and stenosis develop in apoE(-/-) and apoE*3-Leiden transgenic mice.

Lutgens E, de Muinck ED, Heeneman S, Daemen MJ. Lutgens E, et al. Among authors: daemen mj. Arterioscler Thromb Vasc Biol. 2001 Aug;21(8):1359-65. doi: 10.1161/hq0801.093669. Arterioscler Thromb Vasc Biol. 2001. PMID: 11498466

6

Transforming growth factor-beta mediates balance between inflammation and fibrosis during plaque progression.

Lutgens E, Gijbels M, Smook M, Heeringa P, Gotwals P, Koteliansky VE, Daemen MJ. Lutgens E, et al. Among authors: daemen mj. Arterioscler Thromb Vasc Biol. 2002 Jun 1;22(6):975-82. doi: 10.1161/01.atv.0000019729.39500.2f. Arterioscler Thromb Vasc Biol. 2002. PMID: 12067907

7

Genes potentially involved in plaque rupture.

Faber BC, Heeneman S, Daemen MJ, Cleutjens KB. Faber BC, et al. Among authors: daemen mj. Curr Opin Lipidol. 2002 Oct;13(5):545-52. doi: 10.1097/00041433-200210000-00011. Curr Opin Lipidol. 2002. PMID: 12352019 Review.

8

Vasculin, a novel vascular protein differentially expressed in human atherogenesis.

Bijnens AP, Gils A, Jutten B, Faber BC, Heeneman S, Kitslaar PJ, Tordoir JH, de Vries CJ, Kroon AA, Daemen MJ, Cleutjens KB. Bijnens AP, et al. Among authors: daemen mj. Blood. 2003 Oct 15;102(8):2803-10. doi: 10.1182/blood-2003-01-0306. Epub 2003 Jul 3. Blood. 2003. PMID: 12842993 Free article.

9

The dynamic extracellular matrix: intervention strategies during heart failure and atherosclerosis.

Heeneman S, Cleutjens JP, Faber BC, Creemers EE, van Suylen RJ, Lutgens E, Cleutjens KB, Daemen MJ. Heeneman S, et al. Among authors: daemen mj. J Pathol. 2003 Jul;200(4):516-25. doi: 10.1002/path.1395. J Pathol. 2003. PMID: 12845619 Review.

10

Serine protease inhibitor Serp-1 strongly impairs atherosclerotic lesion formation and induces a stable plaque phenotype in ApoE-/-mice.

Bot I, von der Thüsen JH, Donners MM, Lucas A, Fekkes ML, de Jager SC, Kuiper J, Daemen MJ, van Berkel TJ, Heeneman S, Biessen EA. Bot I, et al. Among authors: daemen mj. Circ Res. 2003 Sep 5;93(5):464-71. doi: 10.1161/01.RES.0000090993.01633.D4. Epub 2003 Aug 14. Circ Res. 2003. PMID: 12919945

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

321 results

Search Page